Tae Il Noh, Jong Hyun Tae, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Jeong Gu Lee, Sung Gu Kang
{"title":"单端口机器人辅助前列腺根治术的初步经验:一位外科医生的经验与技术描述","authors":"Tae Il Noh, Jong Hyun Tae, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Jeong Gu Lee, Sung Gu Kang","doi":"10.1016/j.prnil.2021.10.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>With the implementation of da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA), we described our initial experience with the da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA) for single-port robotic-assisted radical prostatectomy (SP-RARP).</p></div><div><h3>Methods</h3><p>This retrospective review included 30 consecutive patients with prostate biopsy-confirmed prostate cancer who underwent SP-RARP by a single surgeon between June and November 2020. SP-RARP was performed with a single-incision plus one method, in which the multichannel guide port was inserted directly with an additional assist port. We report our initial experience of perioperative and early functional outcomes.</p></div><div><h3>Results</h3><p>The mean operative time (SD), console time (SD), and blood loss were 142.8 (15.1) min, 109.9 (15.7) min, and 133.0 (72.9) mL, respectively. No intraoperative complications or blood transfusions were reported. Of the 30 patients, 21 (70.0%), 7 (23.3%) and 2 (6.7%) had stage pT2, pT3a and pT3b disease, respectively. Positive surgical margins were reported in 5 of the 30 (16.7%) patients in the final pathology report, including 2 of 21 (9.5%) with stage pT2 and 3 of 9 (33.3%) with ≥ pT3. At 12 weeks after SP-RARP, 80.0% of patients had achieved continence and the potency was 46.7%; 8 of 11 (72.7%) had sexual health inventory for men (SHIM) scores ≥ 17 and 6 of 19 (31.6%) had SHIM scores < 17.</p></div><div><h3>Conclusions</h3><p>The SP platform for radical prostatectomy was technically safe and feasible. After overcoming the technical learning curve, this platform may provide high-quality outcomes comparable to those of multi-port platforms.</p></div>","PeriodicalId":20845,"journal":{"name":"Prostate International","volume":"10 2","pages":"Pages 85-91"},"PeriodicalIF":2.7000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2287888221000581/pdfft?md5=d611436f8e9ec72b70346ba5278bb2eb&pid=1-s2.0-S2287888221000581-main.pdf","citationCount":"6","resultStr":"{\"title\":\"Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description\",\"authors\":\"Tae Il Noh, Jong Hyun Tae, Ji Sung Shim, Seok Ho Kang, Jun Cheon, Jeong Gu Lee, Sung Gu Kang\",\"doi\":\"10.1016/j.prnil.2021.10.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>With the implementation of da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA), we described our initial experience with the da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA) for single-port robotic-assisted radical prostatectomy (SP-RARP).</p></div><div><h3>Methods</h3><p>This retrospective review included 30 consecutive patients with prostate biopsy-confirmed prostate cancer who underwent SP-RARP by a single surgeon between June and November 2020. SP-RARP was performed with a single-incision plus one method, in which the multichannel guide port was inserted directly with an additional assist port. We report our initial experience of perioperative and early functional outcomes.</p></div><div><h3>Results</h3><p>The mean operative time (SD), console time (SD), and blood loss were 142.8 (15.1) min, 109.9 (15.7) min, and 133.0 (72.9) mL, respectively. No intraoperative complications or blood transfusions were reported. Of the 30 patients, 21 (70.0%), 7 (23.3%) and 2 (6.7%) had stage pT2, pT3a and pT3b disease, respectively. Positive surgical margins were reported in 5 of the 30 (16.7%) patients in the final pathology report, including 2 of 21 (9.5%) with stage pT2 and 3 of 9 (33.3%) with ≥ pT3. At 12 weeks after SP-RARP, 80.0% of patients had achieved continence and the potency was 46.7%; 8 of 11 (72.7%) had sexual health inventory for men (SHIM) scores ≥ 17 and 6 of 19 (31.6%) had SHIM scores < 17.</p></div><div><h3>Conclusions</h3><p>The SP platform for radical prostatectomy was technically safe and feasible. After overcoming the technical learning curve, this platform may provide high-quality outcomes comparable to those of multi-port platforms.</p></div>\",\"PeriodicalId\":20845,\"journal\":{\"name\":\"Prostate International\",\"volume\":\"10 2\",\"pages\":\"Pages 85-91\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2287888221000581/pdfft?md5=d611436f8e9ec72b70346ba5278bb2eb&pid=1-s2.0-S2287888221000581-main.pdf\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prostate International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2287888221000581\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate International","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2287888221000581","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 6
摘要
随着达芬奇SP机器人平台(Intuitive Surgical, Inc., Sunnyvale, CA, USA)的实施,我们描述了我们使用达芬奇SP机器人平台(Intuitive Surgical, Inc., Sunnyvale, CA, USA)进行单端口机器人辅助根治性前列腺切除术(SP- rarp)的初步经验。方法本回顾性研究包括30例连续的前列腺活检确诊的前列腺癌患者,这些患者在2020年6月至11月期间由一名外科医生接受了SP-RARP。SP-RARP采用单切口加一方法,其中多通道引导端口直接插入额外的辅助端口。我们报告围手术期和早期功能结果的初步经验。结果平均手术时间(SD)为142.8 (15.1)min,镇静时间(SD)为109.9 (15.7)min,出血量为133.0 (72.9)mL。无术中并发症及输血。30例患者中,pT2期21例(70.0%),pT3a期7例(23.3%),pT3b期2例(6.7%)。最终病理报告的30例患者中有5例(16.7%)报告手术切缘阳性,其中pT2期21例中有2例(9.5%),pT3≥9例中有3例(33.3%)。SP-RARP治疗12周后,80.0%的患者实现了尿失禁,效价为46.7%;11人中有8人(72.7%)的男性性健康量表(SHIM)得分≥17分,19人中有6人(31.6%)的SHIM得分为<17.结论SP平台在根治性前列腺切除术中技术安全可行。在克服了技术学习曲线后,该平台可以提供与多端口平台相当的高质量结果。
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description
Background
With the implementation of da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA), we described our initial experience with the da Vinci SP robot platform (Intuitive Surgical, Inc., Sunnyvale, CA, USA) for single-port robotic-assisted radical prostatectomy (SP-RARP).
Methods
This retrospective review included 30 consecutive patients with prostate biopsy-confirmed prostate cancer who underwent SP-RARP by a single surgeon between June and November 2020. SP-RARP was performed with a single-incision plus one method, in which the multichannel guide port was inserted directly with an additional assist port. We report our initial experience of perioperative and early functional outcomes.
Results
The mean operative time (SD), console time (SD), and blood loss were 142.8 (15.1) min, 109.9 (15.7) min, and 133.0 (72.9) mL, respectively. No intraoperative complications or blood transfusions were reported. Of the 30 patients, 21 (70.0%), 7 (23.3%) and 2 (6.7%) had stage pT2, pT3a and pT3b disease, respectively. Positive surgical margins were reported in 5 of the 30 (16.7%) patients in the final pathology report, including 2 of 21 (9.5%) with stage pT2 and 3 of 9 (33.3%) with ≥ pT3. At 12 weeks after SP-RARP, 80.0% of patients had achieved continence and the potency was 46.7%; 8 of 11 (72.7%) had sexual health inventory for men (SHIM) scores ≥ 17 and 6 of 19 (31.6%) had SHIM scores < 17.
Conclusions
The SP platform for radical prostatectomy was technically safe and feasible. After overcoming the technical learning curve, this platform may provide high-quality outcomes comparable to those of multi-port platforms.
期刊介绍:
Prostate International (Prostate Int, PI), the official English-language journal of Asian Pacific Prostate Society (APPS), is an international peer-reviewed academic journal dedicated to basic and clinical studies on prostate cancer, benign prostatic hyperplasia, prostatitis, and ...